Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia.


Journal

Blood cancer journal
ISSN: 2044-5385
Titre abrégé: Blood Cancer J
Pays: United States
ID NLM: 101568469

Informations de publication

Date de publication:
08 06 2023
Historique:
received: 16 11 2022
accepted: 22 05 2023
medline: 9 6 2023
pubmed: 8 6 2023
entrez: 7 6 2023
Statut: epublish

Résumé

Whole chromosome losses resulting in near-haploid karyotypes are found in a rare subgroup of treatment-refractory acute lymphoblastic leukemia. To systematically dissect the unique physiology and uncover susceptibilities that can be exploited in near-haploid leukemia, we leveraged single-cell RNA-Seq and computational inference of cell cycle stages to pinpoint key differences between near-haploid and diploid leukemia cells. Combining cell cycle stage-specific differential expression with gene essentiality scores from a genome-wide CRISPR-Cas9-mediated knockout screen, we identified the homologous recombination pathway component RAD51B as an essential gene in near-haploid leukemia. DNA damage analyses revealed significantly increased sensitivity of RAD51-mediated repair to RAD51B loss in the G2/M stage of near-haploid cells, suggesting a unique role of RAD51B in the homologous recombination pathway. Elevated G2/M and G1/S checkpoint signaling was part of a RAD51B signature expression program in response to chemotherapy in a xenograft model of human near-haploid B-ALL, and RAD51B and its associated programs were overexpressed in a large panel of near-haploid B-ALL patients. These data highlight a unique genetic dependency on DNA repair machinery in near-haploid leukemia and demarcate RAD51B as a promising candidate for targeted therapy in this treatment-resistant disease.

Identifiants

pubmed: 37286545
doi: 10.1038/s41408-023-00863-1
pii: 10.1038/s41408-023-00863-1
pmc: PMC10247733
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

92

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Nat Methods. 2013 Oct;10(10):977-9
pubmed: 23892898
Leukemia. 2016 Sep;30(9):1832-43
pubmed: 27174491
Blood. 2012 Jan 26;119(4):911-23
pubmed: 22065598
Nat Biotechnol. 2011 Jan;29(1):79-83
pubmed: 21131983
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Cytometry. 1987 Jan;8(1):1-8
pubmed: 3803091
Nat Rev Mol Cell Biol. 2016 May;17(5):308-21
pubmed: 26956196
Blood Cancer J. 2014 Aug 01;4:e232
pubmed: 25083816
Front Mol Biosci. 2018 Jul 25;5:68
pubmed: 30090811
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9367-9372
pubmed: 28808015
Blood. 2007 Aug 15;110(4):1112-5
pubmed: 17473063
J Clin Oncol. 1992 Apr;10(4):606-13
pubmed: 1548523
Nat Biotechnol. 2016 Feb;34(2):184-191
pubmed: 26780180
Development. 2013 Jan 1;140(1):3-12
pubmed: 23222436
Blood. 1999 Dec 15;94(12):4036-45
pubmed: 10590047
Cancer Cell. 2016 Apr 11;29(4):574-586
pubmed: 27070704
Nat Methods. 2013 Nov;10(11):1096-8
pubmed: 24056875
Science. 2015 Nov 27;350(6264):1096-101
pubmed: 26472758
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Immunol Today. 1995 Aug;16(8):365-70
pubmed: 7546190
Cell Rep. 2013 Dec 26;5(6):1704-13
pubmed: 24332856
Cell. 2018 Jul 26;174(3):716-729.e27
pubmed: 29961576
Acta Biochim Biophys Sin (Shanghai). 2017 Aug 1;49(8):655-668
pubmed: 28541389
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503
pubmed: 31691815
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Blood. 2004 Oct 15;104(8):2444-51
pubmed: 15039281
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Mol Biol Cell. 2002 Jun;13(6):1977-2000
pubmed: 12058064
Genes Dev. 2001 Dec 15;15(24):3308-18
pubmed: 11751636
Nat Genet. 2013 Mar;45(3):242-52
pubmed: 23334668
Exp Cell Res. 1999 Nov 1;252(2):273-80
pubmed: 10527618
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell. 2014 Oct 9;159(2):440-55
pubmed: 25263330
Cancer. 2003 Dec 15;98(12):2715-22
pubmed: 14669294
Genome Res. 2011 Sep;21(9):1543-51
pubmed: 21816910
Blood. 1990 Mar 1;75(5):1170-7
pubmed: 2306521
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Mol Cell Biol. 1996 Dec;16(12):7133-43
pubmed: 8943369
Cancer Genet Cytogenet. 2001 Jul 15;128(2):108-13
pubmed: 11463448
Eur J Haematol. 2010 Oct;85(4):300-8
pubmed: 20561032

Auteurs

Yunpeng Liu-Lupo (Y)

Department of Biology, Massachusetts Institute of Technology, Cambridge, USA.
MIT Koch Institute for Integrative Cancer Research, Cambridge, USA.
Broad Institute of MIT and Harvard, Cambridge, USA.

James Dongjoo Ham (JD)

Department of Biology, Massachusetts Institute of Technology, Cambridge, USA.
MIT Koch Institute for Integrative Cancer Research, Cambridge, USA.

Swarna K A Jeewajee (SKA)

Department of Biology, Massachusetts Institute of Technology, Cambridge, USA.
MIT Koch Institute for Integrative Cancer Research, Cambridge, USA.

Lan Nguyen (L)

Broad Institute of MIT and Harvard, Cambridge, USA.

Toni Delorey (T)

Broad Institute of MIT and Harvard, Cambridge, USA.

Azucena Ramos (A)

Department of Biology, Massachusetts Institute of Technology, Cambridge, USA.
MIT Koch Institute for Integrative Cancer Research, Cambridge, USA.

David M Weinstock (DM)

Broad Institute of MIT and Harvard, Cambridge, USA.
Dana Farber Cancer Institute, Boston, USA.

Aviv Regev (A)

Department of Biology, Massachusetts Institute of Technology, Cambridge, USA.
MIT Koch Institute for Integrative Cancer Research, Cambridge, USA.
Broad Institute of MIT and Harvard, Cambridge, USA.
Genentech, 1 DNA Way, South San Francisco, USA.

Michael T Hemann (MT)

Department of Biology, Massachusetts Institute of Technology, Cambridge, USA. hemann@mit.edu.
MIT Koch Institute for Integrative Cancer Research, Cambridge, USA. hemann@mit.edu.
Broad Institute of MIT and Harvard, Cambridge, USA. hemann@mit.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH